Top compounds associated with response to BEND5


Feature Type Standardized
Nominal ANOVA
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.21 5e-08
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA Topotecan CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA nelarabine CTRPv2 pan-cancer AAC 0.21 9e-08
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.19 6e-07
Download CSV